Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin alfa vs rFSH in young poor ovarian responders (COMPORT)
NCT01816321Phase 3Completed
- Sponsor
- UZ Brussel
- Start
- Mar 2013
- Primary completion
- May 2016
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of corifollitropin alfa in infertility (2 arms), sponsored by UZ Brussel. Primary endpoint: Ongoing pregnancy rate. Started Mar 2013; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01816321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01816321.